Evidence map›Paper›PMID 24842598›Full record

SynthesisThe lancet. Diabetes & endocrinology2014

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.

Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration

3 registry-linked trialsOpen access · hybridAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in The lancet. Diabetes & endocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 415 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
415citing papers in PubMed, 12 pooled it
25.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03718585 unknown statusnot on this mapstarted 2018, after this paper: background citation

Whole Exome Sequencing Analysis Project in Chronic Kidney Disease Patients With Nocturnal Hypertension

Typeobservational_patient_registrySponsorFifth Affiliated Hospital, Sun Yat-Sen UniversityRan2018 to 2022Enrolled4,000ConditionsHypertension, NephropathyArmswhole exome sequencing analysis
NCT05002322 nacompletednot on this mapstarted 2023, after this paper: background citation

Scaling Out and Scaling Up the Systems Analysis and Improvement Approach to Optimize the Hypertension Diagnosis and Care Cascade for HIV-infected Individuals

TypeinterventionalSponsorEduardo Mondlane UniversityRan2023 to 2025Enrolled18ConditionsHypertensionArmsSystems Analysis and Improvement Approach
NCT07050407 completednot on this mapstarted 2020, after this paper: background citation

Impact of Deferred Clinic Visits on Patients With Cardiovascular Comorbidities: A Prospective Cohort Study

Typeobservational_patient_registrySponsorChinese University of Hong KongRan2020 to 2024Enrolled458ConditionsCardiovascular Risk Factor
3 · Its place in the literature

Who cites it

415 citing papers in PubMed, 12 syntheses or guidelines pooled it, 801 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Pooled it
  13. Trial
  14. Trial
  15. Trial
  16. Trends in prevalence of cardiovascular-kidney-metabolic syndrome stages among US young adults, 2011-2020.American heart journal plus : cardiology research and practice · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Article

355 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration

Funding

Shanghai Womens Health StudyUM1CA182910 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2014 to 2018
$5.9M
Reducing disparities in diabetes through expanded insurance coverage.R01DK090435 · NIDDK · HARVARD SCHOOL OF PUBLIC HEALTH · PI DANAEI, GOODARZ · 2011 to 2014
$1.8M
British Heart Foundation RG/08/014/24067Medical Research Council G0400519Medical Research Council G0801056Medical Research Council MC_U147574245Medical Research Council MC_UP_A620_1016Medical Research Council MC_UU_12011/3Medical Research Council MR/K005901/1Medical Research Council MR/L003120/1NCI NIH HHS UM1 CA182910NIDDK NIH HHS R01 DK090435
6 · The paper itself

Abstract

backgroundHigh blood pressure, blood glucose, serum cholesterol, and BMI are risk factors for cardiovascular diseases and some of these factors also increase the risk of chronic kidney disease and diabetes. We estimated mortality from cardiovascular diseases, chronic kidney disease, and diabetes that was attributable to these four cardiometabolic risk factors for all countries and regions from 1980 to 2010.

methodsWe used data for exposure to risk factors by country, age group, and sex from pooled analyses of population-based health surveys. We obtained relative risks for the effects of risk factors on cause-specific mortality from meta-analyses of large prospective studies. We calculated the population attributable fractions for each risk factor alone, and for the combination of all risk factors, accounting for multicausality and for mediation of the effects of BMI by the other three risks. We calculated attributable deaths by multiplying the cause-specific population attributable fractions by the number of disease-specific deaths. We obtained cause-specific mortality from the Global Burden of Diseases, Injuries, and Risk Factors 2010 Study. We propagated the uncertainties of all the inputs to the final estimates.

findingsIn 2010, high blood pressure was the leading risk factor for deaths due to cardiovascular diseases, chronic kidney disease, and diabetes in every region, causing more than 40% of worldwide deaths from these diseases; high BMI and glucose were each responsible for about 15% of deaths, and high cholesterol for more than 10%. After accounting for multicausality, 63% (10·8 million deaths, 95% CI 10·1-11·5) of deaths from these diseases in 2010 were attributable to the combined effect of these four metabolic risk factors, compared with 67% (7·1 million deaths, 6·6-7·6) in 1980. The mortality burden of high BMI and glucose nearly doubled from 1980 to 2010. At the country level, age-standardised death rates from these diseases attributable to the combined effects of these four risk factors surpassed 925 deaths per 100 000 for men in Belarus, Kazakhstan, and Mongolia, but were less than 130 deaths per 100 000 for women and less than 200 for men in some high-income countries including Australia, Canada, France, Japan, the Netherlands, Singapore, South Korea, and Spain.

interpretationThe salient features of the cardiometabolic disease and risk factor epidemic at the beginning of the 21st century are high blood pressure and an increasing effect of obesity and diabetes. The mortality burden of cardiometabolic risk factors has shifted from high-income to low-income and middle-income countries. Lowering cardiometabolic risks through dietary, behavioural, and pharmacological interventions should be a part of the global response to non-communicable diseases.

fundingUK Medical Research Council, US National Institutes of Health.

Indexed as

Global HealthHealth TransitionAge FactorsCardiovascular DiseasesCohort StudiesCost of IllnessDiabetes ComplicationsFemaleHealth SurveysHumansMaleMetabolic SyndromeProspective StudiesRenal Insufficiency, ChronicRisk AssessmentRisk Factors

Identifiers

PMID24842598
PMCPMC4572741
OpenAlexW2289823333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.